Professor and Vice Chair
Jefferson College of Pharmacy
Thomas Jefferson University
This program has been made available online.
Dr Christine Katlama discusses minimizing ART exposure with dual-therapy and intermittent dosing strategies, from Clinical Care Options (CCO)
Expert HIV faculty analyze new data from AIDS 2022, from Clinical Care Options (CCO)
Dr Babafemi Taiwo discusses the emergence of lenacapavir for the treatment of multidrug-resistant HIV, from Clinical Care Options (CCO)
Diapositivas descargables de Clinical Care Options (CCO) con datos sobre el VIH presentados por los doctores Joseph Eron, Karine Lacombe, Chloe Orkin y Babafemi Taiwo en la IDWeek y el HIV Glasgow de 2022